Seoul, South Korea
South Korea is regarded as the third most important pharmaceutical market in Asia and one of the most important Asian countries for clinical studies to support new drug registrations. The government of South Korea has demonstrated its commitment to establishing the country as a key clinical research location. There are many advantages to conducting clinical research in South Korea including high-quality data, high patient volume, world renowned investigators and state-of-the-art facilities.
#11F, GS Tower, 508 Nonhyeon-ro,
Gangnam-gu, Seoul, 06141, Korea
|PHONE||+82 (0)2 570 0000|
|FAX||+82 (0)2 570 0099|
“The emphasis on education in this region is fantastic! Every day I look forward to sharing ideas with my gifted, innovative and highly diligent co-workers. This is a productive and efficient region with a strong patient pool and very favorable logistics.”
Director of Clinical Operations